Ceramide 2 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 14 to 28 and n has a value ranging from 10 to 16.
How much products actually contain
No product states its amount yet.
Of the products containing it, 2 list it before the 1% line and 0 after it (usually 1% or less).
Products using this ingredient
2 of 2 confirmed · likeliest to carry enough first
Definition
Ceramide 2 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 14 to 28 and n has a value ranging from 10 to 16. The INCI Name, Ceramide 2, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 2 will be retained in the retired monograph, and also published with the new name assignment as either Ceramide NS or Ceramide NG.
Cosmetic roles
Safety & regulatory references
Reviewed by CIR: Safety Assessment of Ceramides as Used in Cosmetics
More data — names, identifiers, properties, test records, literature
Official labels & definitions
JCIA labelling name セラミド2: 本品は、N-アシル化スフィンゴイドで、一般に、次の化学式で表される。
Source: JCIA labelling names (Japan)
Names & identifiers
Related literature
- Dietary ceramide 2-aminoethylphosphonate, a marine sphingophosphonolipid, improves skin barrier function in hairless mice · 2020
- Sphingoid bases of dietary ceramide 2-aminoethylphosphonate, a marine sphingolipid, absorb into lymph in rats · 2018
- Digestion of Ceramide 2-Aminoethylphosphonate, a Sphingolipid from the Jumbo Flying Squid Dosidicus gigas, in Mice · 2017
- The effect of concentration of tackifying agent on adhesive and skin-protective properties of ceramide 2-containing hydrocolloid dressings. · 2015
- A single-center, prospective, randomized, open-label, clinical trial of ceramide 2-containing hydrocolloid dressings versus polyurethane film dressings for pressure ulcer prevention in high-risk surgical patients · 2015